Genscript Biotech Corporation (FRA:G51)

Germany flag Germany · Delayed Price · Currency is EUR
1.625
-0.009 (-0.55%)
At close: Dec 5, 2025
24.05%
Market Cap 3.63B
Revenue (ttm) 705.13M
Net Income (ttm) 2.65B
Shares Out n/a
EPS (ttm) 1.20
PE Ratio 1.37
Forward PE 39.54
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 15
Open 1.625
Previous Close 1.634
Day's Range 1.625 - 1.625
52-Week Range 1.100 - 2.042
Beta n/a
RSI 43.78
Earnings Date n/a

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, pept... [Read more]

Industry Commercial Physical and Biological Research
Founded 2002
Employees 5,568
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol G51
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.